tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Medexus Secures Public Reimbursement for Trecondyv® in Quebec
Company AnnouncementsMedexus Secures Public Reimbursement for Trecondyv® in Quebec
26d ago
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
PremiumCompany Announcements
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
1M ago
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
PremiumCompany Announcements
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
2M ago
Medexus Launches GRAFAPEX in US, Eyes $100M Revenue
PremiumCompany Announcements
Medexus Launches GRAFAPEX in US, Eyes $100M Revenue
3M ago
Positive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable Performance
PremiumRatings
Positive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable Performance
3M ago
Medexus Pharmaceuticals: Robust Earnings Amidst Challenges
PremiumCompany AnnouncementsMedexus Pharmaceuticals: Robust Earnings Amidst Challenges
3M ago
Medexus Pharmaceuticals Inc.: Balancing Growth Potential and Risks with a Hold Rating
Premium
Ratings
Medexus Pharmaceuticals Inc.: Balancing Growth Potential and Risks with a Hold Rating
3M ago
Medexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
Premium
Company Announcements
Medexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
3M ago
Medexus Secures Ontario Public Reimbursement for Trecondyv
PremiumCompany Announcements
Medexus Secures Ontario Public Reimbursement for Trecondyv
3M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Medexus Pharmaceuticals to Discuss Q3 2025 Results in Upcoming Conference Call
PremiumCompany Announcements
Medexus Pharmaceuticals to Discuss Q3 2025 Results in Upcoming Conference Call
3M ago
Medexus Pharmaceuticals Announces $30 Million Public Offering
PremiumCompany Announcements
Medexus Pharmaceuticals Announces $30 Million Public Offering
3M ago
Medexus Pharmaceuticals Launches Public Offering to Enhance Financial Flexibility
PremiumCompany AnnouncementsMedexus Pharmaceuticals Launches Public Offering to Enhance Financial Flexibility
4M ago
Medexus Secures FDA Approval for GRAFAPEX, Eyes $100M Revenue Milestone
Premium
Company Announcements
Medexus Secures FDA Approval for GRAFAPEX, Eyes $100M Revenue Milestone
4M ago
Medexus Secures BC Reimbursement for Trecondyv
Premium
Company Announcements
Medexus Secures BC Reimbursement for Trecondyv
4M ago
Medexus Pharmaceuticals Secures Deal for Trecondyv in Canada
PremiumCompany Announcements
Medexus Pharmaceuticals Secures Deal for Trecondyv in Canada
6M ago
Medexus Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany Announcements
Medexus Pharmaceuticals Reports Strong Q2 2025 Results
6M ago
Medexus Shareholders Show Strong Support at Annual Meeting
PremiumCompany Announcements
Medexus Shareholders Show Strong Support at Annual Meeting
8M ago
Medexus Awaits FDA Decision on Treosulfan After Delay
PremiumCompany Announcements
Medexus Awaits FDA Decision on Treosulfan After Delay
8M ago
Medexus Pharmaceuticals Reports Mixed Q1 2025 Results
PremiumCompany AnnouncementsMedexus Pharmaceuticals Reports Mixed Q1 2025 Results
9M ago
Is MDP a Buy, Before Earnings?
Premium
Pre-Earnings
Is MDP a Buy, Before Earnings?
9M ago
Medexus Pharmaceuticals Schedules Q1 2025 Earnings Call
Premium
Company Announcements
Medexus Pharmaceuticals Schedules Q1 2025 Earnings Call
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >